Literature DB >> 15559352

Fertility after ovarian drilling by transvaginal fertiloscopy for treatment of polycystic ovary syndrome.

Hervé Fernandez1, Antoine Watrelot, Jean-Dominique Alby, Jacques Kadoch, Amélie Gervaise, Renaud deTayrac, René Frydman.   

Abstract

STUDY
OBJECTIVE: To evaluate fertiloscopy ovarian drilling with bipolar energy in women with clomiphene citrate-resistant polycystic ovary syndrome (PCOS).
DESIGN: Prospective study (Canadian Task Force classification II).
SETTING: University teaching hospital and private clinic. PATIENTS: Eighty women with clomiphene citrate-resistant PCOS. INTERVENTION: Operative transvaginal fertiloscopy with a coaxial bipolar electrode.
MEASUREMENTS AND MAIN RESULTS: During a mean follow-up of 18.1 months (+/- 6.4), 73 women (91%) recovered regular and ovulatory cycles. The cumulative pregnancy rate was 60% (44/73) for spontaneous and stimulated cycles, with 39.7% (29/73) imputed to drilling alone. The mean time to conceive was 3.9 months (range 1-11.8). There were eight miscarriages (18%), and no ectopic pregnancies or multiple pregnancy. No complications occurred.
CONCLUSION: Ovarian drilling by transvaginal fertiloscopy with bipolar electrosurgery appears to be an effective minimally invasive procedure in patients with PCOS resistant to clomiphene citrate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15559352     DOI: 10.1016/s1074-3804(05)60054-0

Source DB:  PubMed          Journal:  J Am Assoc Gynecol Laparosc        ISSN: 1074-3804


  2 in total

Review 1.  Laparoscopic ovarian drilling: An alternative but not the ultimate in the management of polycystic ovary syndrome.

Authors:  Subarna Mitra; Prasanta Kumar Nayak; Sarita Agrawal
Journal:  J Nat Sci Biol Med       Date:  2015 Jan-Jun

2.  The Prevalence of Incidental Endometriosis in Women Undergoing Laparoscopic Ovarian Drilling for Clomiphene-Resistant Polycystic Ovary Syndrome: A Retrospective Cohort Study and Meta-Analysis.

Authors:  Marlene Hager; René Wenzl; Sonja Riesenhuber; Julian Marschalek; Lorenz Kuessel; Daniel Mayrhofer; Robin Ristl; Christine Kurz; Johannes Ott
Journal:  J Clin Med       Date:  2019-08-14       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.